ADHD medication may reduce suicidal risk among Borderline Personality Disorder patients
A recent Original Investigation on Psychiatry has explored the comparative effectiveness of pharmacotherapies on suicidal behaviour in Borderline Personality Disorder or BPD individuals. According to this study, compared with individuals’ nonuse periods, ADHD medication reduces the risk of attempted or completed suicide. None of the other therapeutic options like antipsychotics, antidepressants, mood stabilizers, and benzodiazepines has favourable outcomes, and Benzodiazepines increase the risk of attempted and completed suicide, they said.
This study entitled “Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder” by Johannes Lieslehto, MD, PhD and colleagues is published in JAMA Network Open.
Among BPD individuals, Suicidal behaviour is a significant clinical concern. Data are scarce regarding the effectiveness of pharmacotherapy in reducing suicide risk, and it requires detailed research. The researchers of the present study further researched this background.
The key findings of the study are:
- The data was used from nationwide Swedish register databases.
- There were 22 601 BPD patients with a mean age of 29.2 years.
- The hazard ratio (HR) for attempted or completed suicide was the primary outcome.
- Eight thousand five hundred thirteen hospitalizations due to attempted suicide and 316 completed suicides were observed.
- Using ADHD medication reduces suicidal behaviour risk.
- Treatment with mood stabilizers did not affect the main outcome.
- Antidepressant and antipsychotic treatments elevate the risk of attempted or completed suicide.
- Benzodiazepines had the highest risk of attempted or completed suicide.
In this Swedish nationwide cohort, ADHD medication was the only pharmacological treatment that reduced the risk of suicidal behaviour among BPD patients.
Benzodiazepines should be used with care among such patients as it has a high risk of suicide.
Our study adds to the literature by providing insight concerning pharmacotherapy and suicide risk, which is a major clinical challenge for treating BPD, they said.
Further reading:
Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder. JAMA Netw Open. 2023;6(6):e2317130. doi:10.1001/jamanetworkopen.2023.17130
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.